Temefos

Temefos

SCHEMBL9435846

CNCCO.COP(=S)(OC)Oc1ccc(Sc2ccc(OP(=S)(OC)OC)cc2)cc1

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 5/20 0.40
▸ SMN1; SMN2 Q16637 4/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ CYP3A4 P08684 2/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ THRB P10828 2/20 0.40
▸ TP53 P04637 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ TSHR P16473 1/20 0.38
▸ GAA P10253 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ PTGIR P43119 2/20 0.32
▸ MTNR1A P48039 1/20 0.32
▸ MTNR1B P49286 1/20 0.32
▸ RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Temefos SCHEMBL23303378 0.83 LMNA (0.53) LMNASMN1; SMN2ALDH1A1CYP3A4HSD17B10
Temefos SCHEMBL44105 0.83 LMNA (0.53) LMNASMN1; SMN2ALDH1A1CYP3A4HSD17B10
Temefos SCHEMBL6388031 0.81 LMNA (0.51) LMNASMN1; SMN2ALDH1A1CYP3A4HSD17B10
Temefos SCHEMBL8741692 0.81 LMNA (0.51) LMNASMN1; SMN2ALDH1A1CYP3A4HSD17B10
Temefos SCHEMBL10455340 0.80 LMNA (0.47) LMNASMN1; SMN2ALDH1A1CYP3A4HSD17B10
Temefos SCHEMBL15553439 0.77 LMNA (0.51) LMNASMN1; SMN2ALDH1A1CYP3A4HSD17B10
Temefos SCHEMBL9809762 0.77 LMNA (0.42) LMNASMN1; SMN2ALDH1A1CYP3A4HSD17B10
Temefos SCHEMBL9193178 0.75 LMNA (0.54) LMNASMN1; SMN2ALDH1A1CYP3A4HSD17B10
Temefos SCHEMBL20919592 0.74 ALDH1A1 (0.46) LMNASMN1; SMN2ALDH1A1CYP3A4HSD17B10
Temefos SCHEMBL10748097 0.73 ALDH1A1 (0.39) LMNASMN1; SMN2ALDH1A1CYP3A4HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0586521-A1 CALCIUM, TRACE MINERAL, VITAMIN D AND DRUG THERAPY COMBINATIONS THE PROCTER & GAMBLE COMPANY (US) 1994-03-16 — — EP disclosed
WO-1992021355-A1 CALCIUM, TRACE MINERAL, VITAMIN D AND DRUG THERAPY COMBINATIONS THE PROCTER & GAMBLE COMPANY (US) 1992-12-10 — — WO disclosed
Send feedback